Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 180


Growth hormone receptor antagonism with pegvisomant in insulin resistant non-diabetic men: A phase II pilot study.

Lee AP, Mulligan K, Schambelan M, Murphy EJ, Weiss EJ.

F1000Res. 2017 May 3;6:614. doi: 10.12688/f1000research.11359.1. eCollection 2017.


Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.

Schwarz JM, Noworolski SM, Wen MJ, Dyachenko A, Prior JL, Weinberg ME, Herraiz LA, Tai VW, Bergeron N, Bersot TP, Rao MN, Schambelan M, Mulligan K.

J Clin Endocrinol Metab. 2015 Jun;100(6):2434-42. doi: 10.1210/jc.2014-3678. Epub 2015 Mar 31.


Subchronic sleep restriction causes tissue-specific insulin resistance.

Rao MN, Neylan TC, Grunfeld C, Mulligan K, Schambelan M, Schwarz JM.

J Clin Endocrinol Metab. 2015 Apr;100(4):1664-71. doi: 10.1210/jc.2014-3911. Epub 2015 Feb 6.


Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery.

Campos GM, Rabl C, Havel PJ, Rao M, Schwarz JM, Schambelan M, Mulligan K.

Surg Obes Relat Dis. 2014 Jan-Feb;10(1):1-8. doi: 10.1016/j.soard.2013.07.010. Epub 2013 Jul 20.


Cutis Verticis Gyrata in Men Affected by HIV-Related Lipodystrophy.

Khanijow K, Unemori P, Leslie KS, Mulligan K, Schambelan M, Maurer T.

Dermatol Res Pract. 2013;2013:941740. doi: 10.1155/2013/941740. Epub 2013 Sep 12.


Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone.

Park-Sigal J, Don BR, Porzig A, Recker R, Griswold V, Sebastian A, Duh QY, Portale AA, Shoback D, Schambelan M.

J Bone Miner Res. 2013 Mar;28(3):700-8. doi: 10.1002/jbmr.1791.


Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men.

Rao MN, Schambelan M, Tai VW, Abrams DI, Khatami H, Havel PJ, Sakkas G, Mulligan K.

AIDS Res Treat. 2012;2012:103072. doi: 10.1155/2012/103072. Epub 2012 Aug 27.


Intensive glucose lowering and cardiovascular outcomes.

Winterstein AG, Heckbert SR, Schambelan M.

N Engl J Med. 2011 Jun 9;364(23):2263; author reply 2264. doi: 10.1056/NEJMc1103669#SA1. No abstract available.


Sarcopenia with limited mobility: an international consensus.

Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, Fearon K, Ferrucci L, Fielding RA, Guralnik JM, Harris TB, Inui A, Kalantar-Zadeh K, Kirwan BA, Mantovani G, Muscaritoli M, Newman AB, Rossi-Fanelli F, Rosano GM, Roubenoff R, Schambelan M, Sokol GH, Storer TW, Vellas B, von Haehling S, Yeh SS, Anker SD; Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop.

J Am Med Dir Assoc. 2011 Jul;12(6):403-9. doi: 10.1016/j.jamda.2011.04.014.


Insulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle.

Masharani UB, Maddux BA, Li X, Sakkas GK, Mulligan K, Schambelan M, Goldfine ID, Youngren JF.

PLoS One. 2011 May 11;6(5):e19878. doi: 10.1371/journal.pone.0019878.


Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection.

Scherzer R, Heymsfield SB, Lee D, Powderly WG, Tien PC, Bacchetti P, Shlipak MG, Grunfeld C; Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM).

AIDS. 2011 Jul 17;25(11):1405-14. doi: 10.1097/QAD.0b013e32834884e6.


Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement.

Weinberg ME, Roman MC, Jacob P, Wen M, Cheung P, Walker UA, Mulligan K, Schambelan M.

PLoS One. 2011 Feb 17;6(2):e14709. doi: 10.1371/journal.pone.0014709.


Nutritional recommendations for the management of sarcopenia.

Morley JE, Argiles JM, Evans WJ, Bhasin S, Cella D, Deutz NE, Doehner W, Fearon KC, Ferrucci L, Hellerstein MK, Kalantar-Zadeh K, Lochs H, MacDonald N, Mulligan K, Muscaritoli M, Ponikowski P, Posthauer ME, Rossi Fanelli F, Schambelan M, Schols AM, Schuster MW, Anker SD; Society for Sarcopenia, Cachexia, and Wasting Disease.

J Am Med Dir Assoc. 2010 Jul;11(6):391-6. doi: 10.1016/j.jamda.2010.04.014. Review.


Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.

Rao MN, Mulligan K, Tai V, Wen MJ, Dyachenko A, Weinberg M, Li X, Lang T, Grunfeld C, Schwarz JM, Schambelan M.

J Clin Endocrinol Metab. 2010 Sep;95(9):4361-6. doi: 10.1210/jc.2009-2502. Epub 2010 Jul 7.


Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers.

Taylor SA, Lee GA, Pao VY, Anthonypillai J, Aweeka FT, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C.

J Acquir Immune Defic Syndr. 2010 Nov;55(3):361-4. doi: 10.1097/QAI.0b013e3181e6a7d9.


A genome-wide association study of carotid atherosclerosis in HIV-infected men.

Shrestha S, Irvin MR, Taylor KD, Wiener HW, Pajewski NM, Haritunians T, Delaney JA, Schambelan M, Polak JF, Arnett DK, Chen YD, Grunfeld C.

AIDS. 2010 Feb 20;24(4):583-92. doi: 10.1097/QAD.0b013e3283353c9e.


The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers.

Pao VY, Lee GA, Taylor S, Aweeka FT, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C.

AIDS. 2010 Jan 16;24(2):265-70. doi: 10.1097/QAD.0b013e328333af1c.


Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost.

Campos GM, Rabl C, Peeva S, Ciovica R, Rao M, Schwarz JM, Havel P, Schambelan M, Mulligan K.

J Gastrointest Surg. 2010 Jan;14(1):15-23. doi: 10.1007/s11605-009-1060-y. Epub 2009 Oct 17.


Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting?

Sakkas GK, Schambelan M, Mulligan K.

Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):623-7. doi: 10.1097/MCO.0b013e328331de63. Review.


The acute effects of HIV protease inhibitors on insulin suppression of glucose production in healthy HIV-negative men.

Lee GA, Schwarz JM, Patzek S, Kim S, Dyachenko A, Wen M, Mulligan K, Schambelan M, Grunfeld C.

J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):246-8. doi: 10.1097/QAI.0b013e3181b03214.

Supplemental Content

Loading ...
Support Center